跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,199 条关于
“Zelgen Biopharma”
全部
2,199
临床试验
101
药物
437
机构
244
资讯
1,417
2个月前
BeiGene Raises 2026 Revenue Guidance as Brukinsa Sales Momentum Continues, CEA ADC Data Slated for ESMO 2026
去年
Ankylosing Spondylitis Pipeline Shows Robust Growth with 20+ Therapies in Development
8个月前
AbbVie Secures $1.1B Deal for Zelgen's DLL3-Targeting Cancer Therapy
去年
Spinal Cord Injury and Ankylosing Spondylitis: Advances in Clinical Trials and Therapies
去年
Gecacitinib Shows Superior Efficacy and Safety Over Hydroxyurea in Myelofibrosis Patients
去年
China Adds 90 Innovative Drugs to National Reimbursement List, Boosting Access to Cancer and Rare Disease Treatments
9个月前
Novel Astatine-211 Targeted Alpha Therapy Shows Promise for Radioactive Iodine-Refractory Thyroid Cancer
去年
Thyroid Cancer Pipeline Shows Robust Growth with 50+ Companies Developing Novel Therapies
去年
Gastric Cancer Pipeline Shows Robust Growth with 220+ Therapies in Development Across 200+ Companies
去年
Regen BioPharma Expands HemaXellerate Trial Scope Beyond Aplastic Anemia
第 1 页,共 142 页
上一页
下一页